Michael Morrissey
Chief Executive Officer bij EXELIXIS, INC.
Vermogen: 55 M $ op 29-02-2024
Profiel
Momenteel bekleedt Michael M. Morrissey de functie van President, Chief Executive Officer & Director bij Exelixis, Inc. Dr. Morrissey zit ook in de raad van bestuur van XWPharma Ltd. In zijn vorige loopbaan was Dr. Morrissey Senior Scientist bij Ciba-Geigy Corp. en Vice President-Discovery Research bij Berlex Biosciences. Michael M. Morrissey behaalde een doctoraat aan de Harvard University en een bachelor aan de University of Wisconsin.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
EXELIXIS, INC.
0.82% | 23-02-2024 | 2 492 969 ( 0.82% ) | 55 M $ | 29-02-2024 |
10-05-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Michael Morrissey
Bedrijven | Functie | Begin |
---|---|---|
EXELIXIS, INC. | Chief Executive Officer | 22-07-2010 |
VERA THERAPEUTICS, INC. | Chairman | 24-05-2022 |
XWPharma Ltd.
XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Director/Board Member | 16-12-2020 |
Eerdere bekende functies van Michael Morrissey
Bedrijven | Functie | Einde |
---|---|---|
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Director/Board Member | 01-11-2022 |
Berlex Biosciences | Corporate Officer/Principal | 01-01-2000 |
Ciba-Geigy Corp. | Chief Tech/Sci/R&D Officer | 01-01-1991 |
Opleiding van Michael Morrissey
Harvard University | Doctorate Degree |
University of Wisconsin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
EXELIXIS, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Ciba-Geigy Corp. | Health Technology |
Berlex Biosciences | |
XWPharma Ltd.
XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Health Technology |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Commercial Services |
Vera Therapeutics, Inc. |